Kalexate Powder and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Kalexate Powder and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Kalexate
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kalexate Powder-Pneumococcal Conjugate Vaccine (7-Valent)
- Kalexate Powder-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Kalexate Powder-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Kalexate Powder-Pneumovax 23
- Kalexate Powder-PNV - Omega
- Kalexate Powder-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Kalliga
- Pneumococcal Conjugate Vaccine (13-Valent)-Kalosar
- Pneumococcal Conjugate Vaccine (13-Valent)-Kalydeco
- Pneumococcal Conjugate Vaccine (13-Valent)-Kalydeco (Ivacaftor Granules)
- Pneumococcal Conjugate Vaccine (13-Valent)-Kalydeco (Ivacaftor Tablets)
- Pneumococcal Conjugate Vaccine (13-Valent)-Kanamycin